KEGG   DRUG: Cetuximab sarotalocan sodium
Entry
D11805                      Drug                                   

Name
Cetuximab sarotalocan sodium (genetical recombination) (JAN);
Akalux (TN)
Remark
Therapeutic category: 4299
Product: D11805<JP>
Efficacy
Antineoplastic
Comment
Antibody-photosensitizer conjugate
Target
EGFR [HSA:1956] [KO:K04361]
  Pathway
hsa04010  MAPK signaling pathway
hsa04012  ErbB signaling pathway
hsa05200  Pathways in cancer
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 4  Agents affecting cellular function
  42  Antineoplastics
   429  Miscellaneous
    4299  Others
     D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   EGFR family
    EGFR
     D11805  Cetuximab sarotalocan sodium (genetical recombination) (JAN) <JP>
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D11805
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11805
Other DBs
PubChem: 405226671
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system